Literature DB >> 9704925

Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence.

S Erickson1, O Sangfelt, M Heyman, J Castro, S Einhorn, D Grandér.   

Abstract

Little is known about the molecular background to senescence in T-lymphocytes. In fibroblast systems replicative senescence has been shown to correlate with a number of changes in the expression of the proteins normally regulating progression through the G1 phase of the cell cycle, and recently the Ink4 inhibitor p16 was implicated as a central regulator of replicative senescence in human fibroblasts. It has, however, been claimed that p16 is not expressed in T-lymphocytes. In the present study we have analysed G1 regulating proteins in ageing human T-lymphocytes. We show that PHA and IL-2 stimulated T-lymphocytes cease to proliferate after around 20 population doublings, these cells can not thereafter be restimulated to growth, and were also found to exhibit markers for senescence. We found that T-lymphocytes accumulate p16 and p15 protein during successive population doublings and display high levels of these proteins as they enter into replicative senescence. There was also an increased binding of p16 to the Cdk6 kinase in senescent cells, and a decreased Cdk6 as well as Cdk2 kinase activity. The levels of other G1 regulating proteins were also altered in the senescent cells, such as slightly elevated levels of p21/WAF1, and downregulation of Cdk2 and cyclinD3. The levels of p27/ Kip1 is down regulated in proliferating cells but rise to approximately 15% of the levels in un-stimulated quiescent cells. As a high proportion of T-cell childhood acute lymphoblastic leukaemias have deletions of both p15 and p16, our data suggest that inactivation of these genes makes it possible for leukemic cells to avoid senescence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704925     DOI: 10.1038/sj.onc.1201965

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.

Authors:  K Schoppmeyer; P S Norris; M Haas
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

Review 2.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

3.  Predicting cytotoxic T-cell age from multivariate analysis of static and dynamic biomarkers.

Authors:  Catherine A Rivet; Abby S Hill; Hang Lu; Melissa L Kemp
Journal:  Mol Cell Proteomics       Date:  2010-12-30       Impact factor: 5.911

4.  Human regulatory T cells induce T-lymphocyte senescence.

Authors:  Jian Ye; Xingxu Huang; Eddy C Hsueh; Qunyuan Zhang; Chunling Ma; Yanping Zhang; Mark A Varvares; Daniel F Hoft; Guangyong Peng
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 5.  Forging a signature of in vivo senescence.

Authors:  Norman E Sharpless; Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

Review 6.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

7.  Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.

Authors:  S A Ezhevsky; A Ho; M Becker-Hapak; P K Davis; S F Dowdy
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).

Authors:  M Malumbres; I Pérez De Castro; M I Hernández; M Jiménez; T Corral; A Pellicer
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 9.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

Review 10.  Tumor suppressor mechanisms in immune aging.

Authors:  Yan Liu; Norman E Sharpless
Journal:  Curr Opin Immunol       Date:  2009-06-15       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.